Business Name: |
Giliberti Orazio L MD |
Contact Person: |
Orazio Giliberti |
Address: |
415 Totowa Road, Totowa, New Jersey 07512 |
Phone Number: |
(973) 595-0011 |
Website Address: |
laserandeye.com |
Annual Revenue (USD): |
$500.000 to $999.999 |
Founding Year: |
1986 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Basista M MD - Totowa, NJ 07512 Ravishankar Indira MD - Totowa, NJ 07512 Coleman Scott MD - Totowa, NJ 07512 Chang Cindy MD - Totowa, NJ 07512 Chrucky Roman MD - Totowa, NJ 07512 Chennapragada Kausalya MD - Totowa, NJ 07512 Deshmukh Pratibha S MD - Totowa, NJ 07512 Cozzone John T MD - Totowa, NJ 07512 Kassem Nadim Y MD - Totowa, NJ 07512 Lima Francesco MD - Totowa, NJ 07512 Immedicenter-Bloomfield A Medical Practice Pc - Totowa, NJ 07512 Elias Maurice MD - Totowa, NJ 07512 Karpova Natalia M MD - Totowa, NJ 07512 Odorczuk Marzena MD - Totowa, NJ 07512 Christopher Sullivan Md - Totowa, NJ 07512 Rakhimova Gulbakhor MD - Totowa, NJ 07512 Totowa Ob-Gyn - Totowa, NJ 07512 Total Obgyn - Totowa, NJ 07512 Kabarwal Navneesh K MD - Totowa, NJ 07512 Zodiatis Alexander DO - Totowa, NJ 07512 |
The company Giliberti Orazio L MD provides B2C services in the form of Doctors from its single location in New Jersey.
1 to 4 employees work for Giliberti Orazio L MD, and the business now earns $500.000 to $999.999 per annum.
Giliberti Orazio L MD was launched in 1986 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Giliberti Orazio L MD, please call Orazio Giliberti with the phone number (973) 595-0011 or visit its single location at 415 Totowa Road in Totowa, New Jersey 07512.
The location of the single location can also be found using the coordinates 40.90479,-74.21213.
Read more details about this business on the webpage laserandeye.com or follow the company’s social media accounts, on Twitter and on Facebook.